ReviewFrontiers in immunology2020

Current Developments of Clinical Sequencing and the Clinical Utility of Polygenic Risk Scores in Inflammatory Diseases.

Matthias Hübenthal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.